Expands the share buyback framework and conducts purchases using systems such as ToSTNeT-3. The total number of shares for acquisition cap is 500,000 shares, the total amount cap is 573,000,000 yen, and the acquisition period is 2026\/2\/6\u20132027\/2\/5.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9780","jir_company_name":"Harima Biostem Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/9780-20260909-01.pdf","jir_short_summary":"Expands the share buyback framework and conducts purchases using systems such as ToSTNeT-3. The total number of shares for acquisition cap is 500,000 shares, the total amount cap is 573,000,000 yen, and the acquisition period is 2026\/2\/6\u20132027\/2\/5.","jir_summary":"### Section heading\nThis press release is a notice confirming the specific acquisition framework and methods after resolving to expand treasury stock acquisition as part of shareholder returns aligned with the medium-term management plan. The target is common stock, and an integrated use of ToSTNeT-3 and market purchases is planned, expanding the total cap from 400,000 shares to 900,000 shares and increasing the total acquisition amount from 300,000,000 yen to 925,000,000 yen. The acquisition period remains the same, and the acquisition method combines ToSTNeT-3 and market purchases.\n\n### Section 2 heading\nThe acquisition date is today, and ToSTNeT-3 purchase orders based on the closing price will be executed at 8:45 AM. The maximum number of shares acquired is 500,000, representing 5.55% of outstanding shares, and the total acquisition amount cap is 573,000,000 yen. Please note that some or all acquisitions may not occur depending on sell orders and other conditions.","jir_financial_highlights":"Total number of shares that can be acquired: 500,000 \u682a (Cap expanded (4.44%\u21925.55% equivalent))\nTotal amount of shares to be acquired: 573,000,000 \u5186 (Cap amount expanded)\nAcquisition period: 2026\u5e742\u67086\u65e5\u304b\u30892027\u5e742\u67085\u65e5\u307e\u3067 (No change)","jir_category":"","jir_hashtags":"#HarimaBiostem Expansion of existing treasury stock framework, #Treasury stock acquisition expansion and ToSTNeT-3, #Capital policy","jir_key_figures":"Key figure 1: 500,000 shares (total number of shares that can be acquired)\nKey figure 2: 573,000,000 yen (total amount of shares that can be acquired)\nKey figure 3: 2026\u5e742\u67086\u65e5\u304b\u3089 2027\u5e742\u67085\u65e5\u307e\u3067 (acquisition period)","jir_meta_title":"Harima Biostem Co., Ltd. Expands Share Buyback Framework and initiates purchases via ToSTNeT-3 | September 2026","jir_meta_description":"Harima Biostem expands its treasury stock framework and discloses a plan including purchases via ToSTNeT-3. Cap: up to 500,000 shares, total amount up to 573 million yen, acquisition period 2026\/2\/6\u20132027\/2\/5. Aimed at enhancing shareholder return flexibility as part of capital policy.","jir_og_title":"Harima Biostem expands treasury stock framework and ToSTNeT-3 purchases","jir_og_description":"Harima Biostem expands treasury stock framework and conducts purchases via ToSTNeT-3. Up to 500,000 shares and up to 573 million yen, period 2026\/2\/6\u20132027\/2\/5.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":0,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-111892","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n